Skip to main content
SCI logo

SCI — Investor Relations & Filings

Ticker · 4119 ISIN · TW0004119003 TW Manufacturing
Open in API
Filings indexed 1,697 across all filing types
Latest filing 2021-04-13 Director's Dealing
Country TW Taiwan
Listing TW 4119

About SCI

www.sci-pharmtech.com.tw

SCI Pharmtech, Inc. specializes in the research, development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, and specialty chemicals. Established in 1987 and originally founded by the Swiss Siegfried Group, the company provides high-quality chemical solutions and custom manufacturing services to leading global pharmaceutical corporations across Europe, North America, and Japan. Its core operations encompass advanced chemical synthesis, process optimization, and large-scale production within GMP-compliant facilities. With a robust R&D infrastructure including specialized laboratories and pilot plants, the company delivers technical excellence in complex chemical processing. SCI Pharmtech maintains a strong focus on quality assurance and international regulatory compliance, positioning itself as a reliable partner for the global healthcare and life sciences sectors.

Recent filings

Filing Released Lang Actions
110年03月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tables listing shareholdings and changes in shareholdings by insiders, including directors, managers, and their related parties. It includes data on stock types, share counts at different times, increases and decreases in holdings, and notes on identities and roles. There is no indication of financial statements, earnings data, or management discussion. The content is focused on insider share transactions and holdings disclosures. This matches the definition of Director's Dealing (DIRS), which reports personal share transactions by company directors and executives (insider trades). The document length is sufficient and the content is substantive insider shareholding data, not a mere announcement or certification. Therefore, the correct classification is DIRS with high confidence.
2021-04-13 Chinese
110年03月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabulation of shareholdings by insiders and related parties of the company 旭富製藥科技股份有限公司. It lists the number of shares held by directors, independent directors, managers, and other insiders, including pledged shares and shares held by spouses or minors. The document does not contain financial statements, earnings data, or management discussion. It is a disclosure of insider shareholdings, which corresponds to reporting of personal share transactions or holdings by company directors and executives. Given the nature of the data and the focus on insider holdings, the document fits best under the category 'Director's Dealing' (DIRS). The document length is 3148 characters, which is consistent with a detailed insider shareholding report rather than a brief announcement or a full financial report. Therefore, the classification is DIRS with high confidence.
2021-04-13 Chinese
110年3月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company, providing information about loan balances and guarantee endorsements, all of which are zero. It is very short (601 characters) and contains tabular data about financial guarantees and loans but no detailed financial statements or analysis. There is no indication of it being a full report like an Annual Report (10-K) or Interim Report (IR). It is not a certification or announcement of a report publication. The content fits best as a Regulatory Filing (RNS) because it is a general regulatory disclosure that does not fit into more specific categories like capital updates or earnings releases.
2021-04-09 Chinese
110年3月營業收入
Regulatory Filings Classification · 90% confidence The document is a revenue summary report for a company named 旭富 for the period 民國110年03月 (March 2021). It contains monthly and cumulative net operating revenue figures, percentage changes compared to the previous year, and explanations for significant changes (notably a fire affecting production). The document is short (784 characters) and provides financial data but is not a full financial report like an Annual Report or Interim Report. It appears to be a regulatory disclosure of revenue figures and explanations, typical of a Regulatory Filing (RNS) category, as it does not contain comprehensive financial statements or detailed analysis. There is no indication it is an announcement of a report publication or a certification. Therefore, the best fit is Regulatory Filings (RNS).
2021-04-09 Chinese
公告本公司109年度第4季自結稅前損益與會計師查核數差異原因說明。
Regulatory Filings Classification · 95% confidence The document is a short announcement (651 characters) from a company (4119 旭富) explaining the difference between its self-reported pre-tax loss for Q4 109 (2020) and the auditor's audited pre-tax loss. It provides specific financial figures and the reason for the discrepancy (fire damage compensation loss). The document is not a full financial report but a regulatory announcement explaining a variance in financial results. It does not contain comprehensive financial statements or detailed analysis typical of an Interim/Quarterly Report (IR). It is also not a certification letter or a report publication announcement. Given the nature and length, it fits best as a Regulatory Filing (RNS), which covers miscellaneous regulatory announcements that do not fit other categories.
2021-04-01 Chinese
109年度財務比率
Fund Information / Factsheet Classification · 90% confidence The document contains a financial data analysis summary for the company 旭富 over three fiscal years (107年度, 108年度, 109年度). It includes various financial ratios and performance metrics such as debt to asset ratio, liquidity ratios, turnover rates, profitability ratios, and cash flow ratios. The document is relatively short (1026 characters) and presents summarized financial data rather than a full detailed report. There is no indication that this is a full Annual Report (10-K) or Interim Report (IR), nor is it an announcement or certification. It appears to be a brief financial summary or factsheet provided by the company. Given the concise nature and summary format, the best fitting category is Fund Information / Factsheet (FS).
2021-03-30 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.